Search Results - Pretto, Chrystel M

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Response of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Messenger Ribonucleic Acids to Ovarian Steroids in Human Endometrial Explants Mimics Their Gene- and Phase-Specific Differential Control in Vivo

    Response of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Messenger Ribonucleic Acids to Ovarian Steroids in Human Endometrial Explants Mimics Their Gene- a... by Vassilev, Vassil, Pretto, Chrystel M., Cornet, Patricia B., Delvaux, Denis, Eeckhout, Yves, Courtoy, Pierre J., Marbaix, Etienne, Henriet, Patrick

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Production of Interleukin-1α by Human Endometrial Stromal Cells Is Triggered during Menses and Dysfunctional Bleeding and Is Induced in Culture by Epithelial Interleukin-1α Released upon Ovarian Steroids Withdrawal

    Production of Interleukin-1α by Human Endometrial Stromal Cells Is Triggered during Menses and Dysfunctional Bleeding and Is Induced in Culture by Epithelial Interleukin-1α Release... by Pretto, Chrystel M., Gaide Chevronnay, Héloïse P., Cornet, Patricia B., Galant, Christine, Delvaux, Denis, Courtoy, Pierre J., Marbaix, Etienne, Henriet, Patrick

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal

    Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha... by Pretto, Chrystel M, Gaide Chevronnay, Héloïse P, Cornet, Patricia B, Galant, Christine, Delvaux, Denis, Courtoy, Pierre J, Marbaix, Etienne, Henriet, Patrick

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Production of lnterleukin-1 α by Human Endometrial Stromal Cells Is Triggered during Menses and Dysfunctional Bleeding and Is Induced in Culture by Epithelial lnterleukin-1α Released upon Ovarian Steroids Withdrawal

    Production of lnterleukin-1 α by Human Endometrial Stromal Cells Is Triggered during Menses and Dysfunctional Bleeding and Is Induced in Culture by Epithelial lnterleukin-1α Releas... by PRETTO, Chrystel M, GAIDE CHEVRONNAY, Héloïse P, CORNET, Patricia B, GALANT, Christine, DELVAUX, Denis, COURTOY, Pierre J, MARBAIX, Etienne, HENRIET, Patrick

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 + T-lymphocyte counts

    Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 + T-lymphocyte counts by Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos

    Published in CNS oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity

    First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on comb... by Schijns, Virgil E.J.C, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M, Chen, Thomas C, Mespouille, Pascal, Hantos, Peter, Glorieux, Philippe, Bota, Daniela A, Stathopoulos, Apostolos

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Therapeutic Immunization against Glioblastoma

    Therapeutic Immunization against Glioblastoma by Schijns, Virgil E J C, Pretto, Chrystel, Strik, Anna M, Gloudemans-Rijkers, Rianne, Deviller, Laurent, Pierre, Denis, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank P K, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Bota, Daniela A, Stathopoulos, Apostolos

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation

    Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation by Stathopoulos, Apostolis, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Kruse, Carol, Jadus, Martin, Chen, Thomas C., Schijns, Virgil E.J.C.

    Published in Oncoimmunology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS

    ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS by Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-tang, Beverly Fu, Dan, Hsu, Frank P K, Schönthal, Alex H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil E J C, Stathopoulos, Apostolos

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4

    Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 by Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos

    Published in CNS oncology
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report

    Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report by Bota, Daniela A, Alexandru-Abrams, Daniela, Pretto, Chrystel, Hofman, Florence M, Chen, Thomas C, Fu, Beverly, Carrillo, Jose A, Schijns, Virgil Ejc, Stathopoulos, Apostolos

    Published in Permanente journal
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: